Data Collective IV GP, LLC
CIK
1664974
Location
PALO ALTO, CA
Portfolio Value
Micro
$55,949,943
Diversification
Highly concentrated
Filing Date
Global Rank
#6,337
/ 8,232
▲ 220
Top Industry
Security & Protection Services
49.6%
3Y Alpha vs SPY
+0.6%
Period ended 2 months ago
Filed May 15, 2026 · 30d
18 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+78.9%
SPY
+76.3%
Annualised alpha
+0.6%
Max drawdown
−60.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
4 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
49.6%
−7.9 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
3,744
Highly concentrated−1,368
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Industrials | 49.6% | $27,769,500 |
| Healthcare | 36.0% | $20,135,853 |
| Technology | 14.4% | $8,044,590 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
4 positions ·
$55,949,943 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVLV |
Evolv Technologies Holdings, Inc.
Industrials
|
Held | 4,590,000 | $27,769,500 | 49.63% | |
| RXRX |
Recursion Pharmaceuticals, Inc.
Healthcare
|
Held | 5,941,120 | $18,239,238 | 32.60% | |
| HQ |
Horizon Quantum Holdings Ltd.
Technology
|
NEW | 915,198 | $8,044,590 | 14.38% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 100,350 | $1,896,615 | 3.39% |